CLDF Title
Home | Contact Us | Bookmark
 
 
About CLDF Centers of Educational Expertise  
 
Back Hepatology Centers of Educational Expertise
Banner
 
Dr. Kwo
Paul Y. Kwo, MD, is a Professor of Medicine (Gastroenterology & Hepatology) at The Stanford University Medical Center. After receiving his medical degree from Wayne State University School of Medicine in Detroit, Michigan, Dr. Kwo completed an internship and a residency in Baltimore at the University of Maryland. He completed his specialty training with a fellowship in gastroenterology and hepatology at the Mayo Clinic in Rochester, Minnesota.
  More
 
  Ask the Expert 
Ask a Question
 
  CME and Independent Education  
 
   
 
 
 
  Physician Resources 
 
 
  My Publications More  
 
  Peginterferon and ribavirin for treatment of recurrent hepatitis C disease in HCV-HIV coinfected liver transplant recipients.
 
  Telaprevir with peginterferon/ribavirin for retreatment of null responders with advanced fibrosis post-orthotopic liver transplant.
 
  Management of hyponatremia in clinical hepatology practice.
 
  Role of cardiac catheterization and percutaneous coronary intervention in the preoperative assessment and management of patients before orthotopic liver transplantation.
 
  Safety and efficacy of boceprevir/peginterferon/ribavirin for HCV G1 compensated cirrhotics: Meta-analysis of 5 trials.
 
 
  Disease Educational Content  
 
  Hepatic Encephalopathy Update: Reports from the 64th Annual Meeting of the American Association for the Study of Liver Diseases
  Educational eNewsletter
   
   
  Hepatic Encephalopathy: A Review of Diagnostic Methods
  Educational eNewsletter
   
  Hepatic Encephalopathy Update: Prophylactic Therapy to Prevent Hepatic Encephalopathy
  Educational eNewsletter
   
   
 
   
   
 
  Institution Information
Stanford Medicine is committed to building partnerships within the local community to further promote community health. Through a deep understanding of common goals and a strong belief in healthy living, these community relationships help to develop and enhance public awareness through education, research, outreach and public service. By establishing and maintaining strong partnerships, Stanford Medicine can be a positive voice and advocate for community health.
 
 
Current Studies  
Institution Link  
 
     
 
Liver News - REUTERS
 
  Novo Nordisk and Gilead team up to test fatty liver disease treatment  
  04-12-2019  
     
  Clusters of autoimmune liver disease suggest environmental trigger  
  04-11-2019  
     
  US liver cancer deaths more common with less education  
  04-08-2019  
     
  Fecal microbiome signature detects cirrhosis in nonalcoholic fatty-liver disease  
  04-04-2019  
     
  View Complete News Library  
  Line  
  Journal Abstracts  
  Real-world safety and effectiveness of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin in hepatitis C virus genotype 1- and 4-infected patients with diverse comorbidities and comedications: A pooled analysis of post-marketing observational studies from 13 countries  
     
  Impact of hepatitis C treatment on pain intensity, prescription opioid use and arthritis  
     
  Evidence-based and guideline-concurrent responses to narratives deferring HCV treatment among people who inject drugs  
     
  Priorities and recommended actions for how researchers, practitioners, policy makers, and the affected community can work together to improve access to hepatitis C care for people who use drugs  
     
  Vitamin D deficiency and health-related quality of life in chronic hepatitis C  
     
  Utility of bevacizumab in advanced hepatocellular carcinoma: A veterans affairs experience  
     
  View All Articles  
  Line  
  Congress Calendar  
     
  View All Conventions  
     
 
                 
 
HBV
Webcasts
Slide Library
Abstract Library
 
HE
Live CME Meetings
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Live CME Meetings
Webcasts
Slide Library
Abstract Library
 
CLDF Follow Us
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Sponsors & Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Hepatology
Substance Use Disorder
     
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2019 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare
providers only. Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.